中文
About Us
Corporate Overview
Management Team
Board of Directors
Contact Us
Our Focus
Viral Diseases
NASH/PBC
Cancer
Exploratory Indications
Products&Pipeline
Pipeline
Products
Clinical Trials
Partnership
Investors
Financials & Filing
Presentation Materials
News
Careers
Investors
Financials & Filing
Presentation Materials
Next Day Disclosure Returns - Others
2023-08-15
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023
2023-08-02
Voluntary Announcement - Shanghai Public Health Clinical Center Presented Clinical Results of ASC22 (Envafolimab) in Combination with Chidamide for Functional Cure of HIV Infection at the 12th IAS Conference on HIV Science
2023-07-25
Notice of Board Meeting
2023-07-21
Next Day Disclosure Returns - Share Buyback
2023-07-20
Voluntary Announcement - Gannex Announces the Completion of Patient Enrollment for Phase II Clinical Trial of ASC42, an FXR Agonist, for Primary Biliary Cholangitis
2023-07-20
Next Day Disclosure Returns - Share Buyback
2023-07-19
Positive Profit Alert
2023-07-18
Next Day Disclosure Returns - Share Buyback
2023-07-14
Next Day Disclosure Returns - Share Buyback
2023-07-13
«
2
3
4
5
»